RU2003117815A - METHOD FOR TREATING INAPERABLE LUNG CANCER - Google Patents
METHOD FOR TREATING INAPERABLE LUNG CANCERInfo
- Publication number
- RU2003117815A RU2003117815A RU2003117815/14A RU2003117815A RU2003117815A RU 2003117815 A RU2003117815 A RU 2003117815A RU 2003117815/14 A RU2003117815/14 A RU 2003117815/14A RU 2003117815 A RU2003117815 A RU 2003117815A RU 2003117815 A RU2003117815 A RU 2003117815A
- Authority
- RU
- Russia
- Prior art keywords
- incubated
- patient
- focal dose
- chemotherapy
- irradiation
- Prior art date
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims 2
- 201000005202 lung cancer Diseases 0.000 title claims 2
- 208000020816 lung neoplasm Diseases 0.000 title claims 2
- 238000000034 method Methods 0.000 title claims 2
- 210000002751 lymph Anatomy 0.000 claims 4
- 238000002512 chemotherapy Methods 0.000 claims 2
- 230000005855 radiation Effects 0.000 claims 2
- 238000001959 radiotherapy Methods 0.000 claims 2
- 229940044683 chemotherapy drug Drugs 0.000 claims 1
- 210000002978 thoracic duct Anatomy 0.000 claims 1
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003117815/14A RU2257233C2 (en) | 2003-06-16 | 2003-06-16 | Method for treating inoperable pulmonary cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2003117815/14A RU2257233C2 (en) | 2003-06-16 | 2003-06-16 | Method for treating inoperable pulmonary cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2003117815A true RU2003117815A (en) | 2004-12-20 |
| RU2257233C2 RU2257233C2 (en) | 2005-07-27 |
Family
ID=35843695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2003117815/14A RU2257233C2 (en) | 2003-06-16 | 2003-06-16 | Method for treating inoperable pulmonary cancer |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2257233C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2506974C1 (en) * | 2012-11-06 | 2014-02-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method of treating unresectable primary lung cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2107494C1 (en) * | 1993-05-06 | 1998-03-27 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Method for treating pulmonary cancer |
| RU2123342C1 (en) * | 1995-08-29 | 1998-12-20 | Ростовский научно-исследовательский онкологический институт Минздравмедпрома РФ | Method of treatment of patients with lung cancer |
| RU2160110C2 (en) * | 1998-03-12 | 2000-12-10 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Method for treating cancer |
-
2003
- 2003-06-16 RU RU2003117815/14A patent/RU2257233C2/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hardacre et al. | Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study | |
| Xu et al. | Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1/PD-L1-dependent T cell immunization | |
| Tartour et al. | Lung cancer: potential targets for immunotherapy | |
| Al Jarroudi et al. | Anti-programmed cell death protein 1 (PD-1) immunotherapy for metastatic hepatocellular carcinoma after liver transplantation: a report of three cases | |
| De La Maza et al. | In situ vaccination after accelerated hypofractionated radiation and surgery in a mesothelioma mouse model | |
| RU2747124C2 (en) | Methods of treating metastatic pancreatic cancer by a combination therapy comprising administering irinotecan and oxaliplatin | |
| JP2017536408A5 (en) | ||
| RU2018102547A (en) | CONTROL POINT INHIBITORS AND WHOLE CELLS OF MYCOBACTERIA FOR USE IN CANCER THERAPY | |
| CN118903271A (en) | Improving therapeutic index of anti-immune checkpoint inhibitors using combination therapies comprising PHY906 extract, scutellaria extract or compounds derived from these extracts | |
| Mizrahi et al. | Immunotherapy in gastrointestinal malignancies | |
| RU2003117815A (en) | METHOD FOR TREATING INAPERABLE LUNG CANCER | |
| Byrne et al. | CD40 therapy and surgery: a potential immunologic partnership | |
| RU2257233C2 (en) | Method for treating inoperable pulmonary cancer | |
| Zhang et al. | SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial | |
| Prehn et al. | Is an immune reaction required for malignant transformation and cancer growth? | |
| RU2242998C1 (en) | Method for treating pulmonary cancer | |
| RU2311185C2 (en) | Method for conservative treatment in patients at nonoperable pulmonary carcinoma | |
| Gu | Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings | |
| Girard et al. | PD1-1-1 Phase Ib study of BI 836880 (VEGF/Ang2 nanobody®) plus ezabenlimab (BI 754091, anti-PD-1 antibody) in patients with solid tumors | |
| RU2301061C2 (en) | Method for treating generalized skin melanoma | |
| Donde et al. | Immune cell therapy against gastrointestinal tract cancers | |
| RU2257218C1 (en) | Method for complex therapy of pulmonary cancer. | |
| Park et al. | Comparison of Antitumor Effects of Combinations of Immune Checkpoint Inhibitors With Dendritic Cells Intratumorally Injected into Irradiated Mouse Adenocarcinoma | |
| Mishra et al. | The Evolution of Cancer Immunotherapy: A Journey from Concept to Clinical Reality | |
| Ryu et al. | Sea Hare Hydrolysate Reduces PD‐L1 Levels in Cancer Cells and Mitigates Rheumatoid Arthritis Ina Collagen‐Induced Arthritis Mouse Model |